Galapagos NV
GLPG
#4558
Rank
ยฃ1.64 B
Marketcap
ยฃ24.94
Share price
0.00%
Change (1 day)
29.08%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: ยฃ1.64 Billion

As of January 2026 Galapagos NV has a market cap of ยฃ1.64 Billion. This makes Galapagos NV the world's 4558th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ1.64 B1.67%
2025ยฃ1.61 B12.74%
2024ยฃ1.43 B-31.82%
2023ยฃ2.10 B-12.94%
2022ยฃ2.41 B-10.76%
2021ยฃ2.70 B-43.03%
2020ยฃ4.75 B-53.89%
2019ยฃ10.30 B160.55%
2018ยฃ3.95 B11.27%
2017ยฃ3.55 B47.14%
2016ยฃ2.41 B45.19%
2015ยฃ1.66 B353.78%
2014ยฃ0.36 B-3.53%
2013ยฃ0.37 B8.67%
2012ยฃ0.34 B52.36%
2011ยฃ0.22 B-16.73%
2010ยฃ0.27 B74.96%
2009ยฃ0.15 B124.65%
2008ยฃ70.11 M

End of Day market cap according to different sources

On Jan 21st, 2026 the market cap of Galapagos NV was reported to be:

ยฃ1.64 Billion
by Nasdaq info icon info icon
ยฃ1.64 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
ยฃ209.07 B 12,624.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
ยฃ391.19 B 23,707.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ83.53 B 4,984.06%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
ยฃ284.52 B 17,215.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
ยฃ79.98 M-95.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ156.49 B 9,424.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ26.83 B 1,533.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GSK plc
GSK
ยฃ72.35 B 4,303.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ206.69 B 12,479.30%๐Ÿ‡บ๐Ÿ‡ธ USA